Literature DB >> 6204762

Alteration by prolactin of surface charge and membrane fluidity of rat 13762 mammary ascites tumor cells.

D A Zarkower, L D Plank, E Kunze, A Keith, P Todd, W C Hymer.   

Abstract

Intraperitoneal injection of ovine prolactin (100 micrograms/d) in Fischer 344 rats bearing transplantable 13762 mammary ascites tumor (MAT) cells modifies the surface charge density and membrane fluidity of the tumor cells. In each of five experiments the mean electrophoretic mobility (epm) of MAT cells taken from prolactin-treated rats was significantly lower than that of cells from nonhormone-treated controls. Prolactin concentrations were increased in vivo by (a) direct intraperitoneal injection of ovine prolactin; (b) subcutaneous implantation of diethylstilbestrol-containing silastic capsules to produce pituitary prolactin secreting tumors; or (c) a single subcutaneous injection of polyestradiol phosphate, a long-acting estrogen. In an effort to establish that the prolactin effect was a direct one, two in vivo protocols were used: (a) MAT cells were coincubated with anterior pituitary halves obtained from nontumor-bearing littermates; or (b) rat or ovine prolactin was added to serum-free culture media containing MAT cells. In both protocols, the epm of the prolactin-treated cells was significantly lower. The isoelectric focusing pH of whole cells was increased by prolactin treatment from 4.93 to 5.12, consistent with a reduction in the number of surface carboxyl groups. The fluidity of membranes of treated cells was drastically increased, as measured by spin-label probe rotation rates. These combined results imply that the hormone exerts its effect by stimulating events in the cell that lead to a reduction of the average density of carboxylic acid residues on the tumor cell surface.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6204762     DOI: 10.1007/BF02788580

Source DB:  PubMed          Journal:  Cell Biophys        ISSN: 0163-4992


  37 in total

1.  The electrokinetic characterization of the Ehrlich ascites carcinoma cell.

Authors:  G M COOK; D H HEARD; G V SEAMAN
Journal:  Exp Cell Res       Date:  1962-10       Impact factor: 3.905

2.  Sialic acid in the cellular membranes of Ehrlich ascites-carcinoma cells.

Authors:  D F WALLACH; E H EYLAR
Journal:  Biochim Biophys Acta       Date:  1961-09-30

3.  The effects of culture conditions on prolactin and growth hormone production by rat anterior pituitary cells.

Authors:  W W Wilfinger; J A Davis; E C Augustine; W C Hymer
Journal:  Endocrinology       Date:  1979-08       Impact factor: 4.736

4.  Preparative electrophoresis of living mammalian cells in a stationary ficoll gradient.

Authors:  R C Boltz; P Todd; M J Streibel; M K Louie
Journal:  Prep Biochem       Date:  1973

5.  Surface glycoproteins of normal and transformed cells: a difference determined by sialic acid and a growth-dependent sialyl transferase.

Authors:  L Warren; J P Fuhrer; C A Buck
Journal:  Proc Natl Acad Sci U S A       Date:  1972-07       Impact factor: 11.205

6.  Observations on the effect of neuraminidase on the distribution of intravenously injected Walker tumor cells in rats.

Authors:  L Weiss; B Fisher; E R Fisher
Journal:  Cancer       Date:  1974-09       Impact factor: 6.860

7.  Purification of the major sialoglycoproteins of 13762 MAT-B1 and MAT-C1 rat ascites mammary adenocarcinoma cells by density gradient centrifugation in cesium chloride and guanidine hydrochloride.

Authors:  A P Sherblom; R L Buck; K L Carraway
Journal:  J Biol Chem       Date:  1980-01-25       Impact factor: 5.157

8.  A complex of two cell surface glycoproteins from ascites mammary adenocarcinoma cells.

Authors:  A P Sherblom; K L Carraway
Journal:  J Biol Chem       Date:  1980-12-25       Impact factor: 5.157

9.  Non-metastasising variants selected from metastasising melanoma cells.

Authors:  T W Tao; M M Burger
Journal:  Nature       Date:  1977-12-01       Impact factor: 49.962

10.  Differing electrical surface charge and transplantation properties of genetically variant sublines of the TA3 murine adenocarcinoma tumor.

Authors:  T S Tenforde; P O Adesida; L S Kelly; P W Todd
Journal:  Eur J Cancer Clin Oncol       Date:  1983-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.